title: Controlled natural cycle IVF with antagonist use and blastocyst transfer.
abstract: A method of controlled natural cycle IVF (CONCIVF) was sought to provide simpler and shorter treatment without the risks of ovarian hyperstimulation syndrome and multiple pregnancies. A total of 138 couples with normal ovulation and normal sperm parameters, in whom the women were <40 years old, were the candidates for this study. Gonadotrophin-releasing hormone antagonist was used before human chorionic gonadotrophin (HCG) administration if LH increased to a concentration of 10 mIU/ml before HCG injection. Treatment was initiated at > or =16 mm follicular growth and at oestradiol concentrations > or =400 pmol/l with 5000 IU HCG induction. All the embryos were cultured to the blastocyst stage and transferred only if they reached early or advanced blastulation. A total of 126 patients underwent oocyte retrieval. In 102 cases, one oocyte was retrieved; 95% of the oocytes fertilized, 99% cleaved and 47.9% achieved the blastocyst stage. The implantation rate per blastocyst transfer was 53.3% and the live-birth rate per embryo transfer was 40%. Therefore, CONCIVF with blastocyst transfer gives acceptable blastocyst development and implantation rates without the long- or short-term side effects of ovulation induction.
authors.affiliation: Pedieos IVF Centre, Anemomylos Office No. 201, 1095 Nicosia, Cyprus. trokoude@spidernet.com.cy
authors.forename: K M
authors.initials: KM
authors.lastname: Trokoudes
authors.forename: M B
authors.initials: MB
authors.lastname: Minbattiwalla
authors.forename: L
authors.initials: L
authors.lastname: Kalogirou
authors.forename: K
authors.initials: K
authors.lastname: Pantelides
authors.forename: P
authors.initials: P
authors.lastname: Mitsingas
authors.forename: A
authors.initials: A
authors.lastname: Sokratous
authors.forename: A
authors.initials: A
authors.lastname: Chrysanthou
authors.forename: S J
authors.initials: SJ
authors.lastname: Fasouliotis
mesh_terms: D000328:Adult; D006063:Chorionic Gonadotropin / Q000008:administration & dosage; D004624:Embryo Transfer; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods*; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors; D006801:Humans; D007231:Infant, Newborn; D008137:Longitudinal Studies; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D008597:Menstrual Cycle; D011247:Pregnancy; D018873:Pregnancy Rate
chemical_list: D006063:Chorionic Gonadotropin; D007987:Gonadotropin-Releasing Hormone; D007986:Luteinizing Hormone